(Total Views: 461)
Posted On: 03/20/2025 7:08:32 PM
Post# of 154593
Misiu, do you know if this premise still stands?
"Data from these 30 patients are aligned with the premise that a majority of mTNBC patients respond to leronlimab if CTC reduction is observed following one leronlimab dose."
https://www.otcmarkets.com/stock/CYDY/news/Cy...?id=317926
(6)
(0)
